Jackson Financial Inc. Form 8-K Summary
Business context and reporting period
Jackson Financial Inc. filed a Form 8-K dated December 14, 2023, reporting initial regulatory approval to form Brooke Life Reinsurance Company, an affiliated Michigan captive insurer. The filing does not report quarterly or annual operating results.
Key financial metrics and capital position
- The filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures.
- Brooke Re is expected to be funded in January 2024 through a return-of-capital distribution from Jackson to Brooke Life, subject to Michigan Department of Insurance and Financial Services approval.
- Based on current market conditions and funding estimates, Jackson expects no impact on holding-company cash and highly liquid securities.
- Jackson’s risk-based capital ratio is expected to remain within or above its targeted 425%–500% range.
Material changes and proposed transaction
- Jackson expects to enter into a reinsurance transaction with Brooke Re in the first quarter of 2024, with economic effects effective January 1, 2024.
- The transaction is expected to be structured as 100% coinsurance with funds withheld.
- Jackson would cede liabilities related to certain guaranteed benefit riders and other market risk benefits under variable annuity and similar products, including both in-force and future business written on a flow basis.
- Jackson would retain the variable annuity base contract, contract administration, investment management of the funds-withheld assets, and hedging responsibilities for Brooke Re and its retained liabilities.
- Brooke Re would use a modified GAAP approach primarily for market risk benefits, intended to improve asset-liability alignment and reduce the impact of the cash surrender value floor on statutory capital requirements.
Outlook, risks, and contingencies
- Permanent approval is expected to enable Brooke Re to begin operations promptly after funding, but the transaction remains subject to required regulatory approvals and closing conditions.
- Funding estimates and the expected capital impact will be updated as of the transaction’s effective date.
- Jackson expects the arrangement to support more efficient economic hedging and reduce non-economic hedging costs, while requiring higher levels of interest-rate hedging for Brooke Re.
- Management expects to provide additional Brooke Re details and 2024 financial targets with the late-February 2024 earnings announcement for the year and quarter ended December 31, 2023.
- Actual results may differ materially from forward-looking statements because of market conditions, regulatory approvals, funding requirements, hedging results, capital requirements, and other risks identified in Jackson’s SEC filings.
Facts investors should verify
- Michigan DIFS approval of the return-of-capital distribution and Brooke Re’s permanent operating approval.
- Completion and final terms of the reinsurance transaction in the first quarter of 2024.
- The final amount of capital transferred to Brooke Re and any effect on holding-company liquidity.
- The transaction’s actual effect on Jackson’s total adjusted capital, statutory required capital, and risk-based capital ratio.
- The 2024 financial targets and updated capital outlook disclosed with the February 2024 earnings release.